Consensus guidelines on screening for hypopituitarism following traumatic brain injury

E. Ghigo, Brent Masel, G. Aimaretti, J. Léon-Carrión, F. F. Casanueva, M. R. Dominguez-Morales, E. Elovic, K. Perrone, G. Stalla, C. Thompson, Randall Urban

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

Primary objective: The goal of this consensus statement is to increase awareness among endocrinologists and physicians treating patients with traumatic brain injury (TBI) of the incidence and risks of hypopituitarism among patients with TBI. Rationale: TBI poses significant risk to the pituitary gland, leading to elevated risks of diabetes, hypopituitarism and other endocrinopathies. Signs and symptoms associated with hypopituitarism often mimic the sequellae of TBI, although the severity of symptoms is not necessarily related to the severity of the injury. Patients with TBI-induced hypopituitarism may benefit both physically and psychologically from appropriate hormone replacement therapy (HRT). Participants at this unique consensus meeting attempted to define and spearhead an approach to increase awareness of the risks of TBI-induced endocrinopathies, in particular growth hormone deficiency (GHD), and to outline necessary and practical objectives for managing this condition. Recommendations: Systematic screening of pituitary function is recommended for all patients with moderate-to-severe TBI at risk of developing pituitary deficits. Patients with hypopituitarism benefit from appropriate hormonal replacement and prospects for rehabilitation of patients with TBI-induced hypopituitarism may be enhanced by appropriate HRT. Further exploration of this possibility requires: (1) active collaboration between divisions of endocrinology and rehabilitation at the local level to perform a screening of pituitary function in patients after TBI, (2) creation of a consultancy service by endocrine societies for use by rehabilitation centres, (3) development of continuing medical education (CME) programmes that can be offered as crossover training to the physicians who manage the care of patients with TBIs, (4) targeting of patient organizations with educational information for dissemination to patients and their families, (5) continued efforts to more clearly define the population at greatest risk of TBI-induced hypopituitarism and (6) monitor results of efficacy studies as they become available to evaluate whether and how much replacement therapy can improve the symptoms of individuals with TBI-induced hypopituitarism.

Original languageEnglish (US)
Pages (from-to)711-724
Number of pages14
JournalBrain Injury
Volume19
Issue number9
DOIs
StatePublished - Aug 20 2005

Fingerprint

Hypopituitarism
Consensus
Guidelines
Hormone Replacement Therapy
Traumatic Brain Injury
Rehabilitation
Physicians
Continuing Medical Education
Rehabilitation Centers
Information Dissemination
Endocrinology
Pituitary Gland
Growth Hormone
Signs and Symptoms
Patient Care
Organizations

Keywords

  • Growth hormone efficiency
  • Head trauma
  • Hypopituitarism
  • Traumatic brain injury

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Ghigo, E., Masel, B., Aimaretti, G., Léon-Carrión, J., Casanueva, F. F., Dominguez-Morales, M. R., ... Urban, R. (2005). Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Injury, 19(9), 711-724. https://doi.org/10.1080/02699050400025315

Consensus guidelines on screening for hypopituitarism following traumatic brain injury. / Ghigo, E.; Masel, Brent; Aimaretti, G.; Léon-Carrión, J.; Casanueva, F. F.; Dominguez-Morales, M. R.; Elovic, E.; Perrone, K.; Stalla, G.; Thompson, C.; Urban, Randall.

In: Brain Injury, Vol. 19, No. 9, 20.08.2005, p. 711-724.

Research output: Contribution to journalArticle

Ghigo, E, Masel, B, Aimaretti, G, Léon-Carrión, J, Casanueva, FF, Dominguez-Morales, MR, Elovic, E, Perrone, K, Stalla, G, Thompson, C & Urban, R 2005, 'Consensus guidelines on screening for hypopituitarism following traumatic brain injury', Brain Injury, vol. 19, no. 9, pp. 711-724. https://doi.org/10.1080/02699050400025315
Ghigo E, Masel B, Aimaretti G, Léon-Carrión J, Casanueva FF, Dominguez-Morales MR et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Injury. 2005 Aug 20;19(9):711-724. https://doi.org/10.1080/02699050400025315
Ghigo, E. ; Masel, Brent ; Aimaretti, G. ; Léon-Carrión, J. ; Casanueva, F. F. ; Dominguez-Morales, M. R. ; Elovic, E. ; Perrone, K. ; Stalla, G. ; Thompson, C. ; Urban, Randall. / Consensus guidelines on screening for hypopituitarism following traumatic brain injury. In: Brain Injury. 2005 ; Vol. 19, No. 9. pp. 711-724.
@article{e7d3f7ee053b4879919285a3dae8f58e,
title = "Consensus guidelines on screening for hypopituitarism following traumatic brain injury",
abstract = "Primary objective: The goal of this consensus statement is to increase awareness among endocrinologists and physicians treating patients with traumatic brain injury (TBI) of the incidence and risks of hypopituitarism among patients with TBI. Rationale: TBI poses significant risk to the pituitary gland, leading to elevated risks of diabetes, hypopituitarism and other endocrinopathies. Signs and symptoms associated with hypopituitarism often mimic the sequellae of TBI, although the severity of symptoms is not necessarily related to the severity of the injury. Patients with TBI-induced hypopituitarism may benefit both physically and psychologically from appropriate hormone replacement therapy (HRT). Participants at this unique consensus meeting attempted to define and spearhead an approach to increase awareness of the risks of TBI-induced endocrinopathies, in particular growth hormone deficiency (GHD), and to outline necessary and practical objectives for managing this condition. Recommendations: Systematic screening of pituitary function is recommended for all patients with moderate-to-severe TBI at risk of developing pituitary deficits. Patients with hypopituitarism benefit from appropriate hormonal replacement and prospects for rehabilitation of patients with TBI-induced hypopituitarism may be enhanced by appropriate HRT. Further exploration of this possibility requires: (1) active collaboration between divisions of endocrinology and rehabilitation at the local level to perform a screening of pituitary function in patients after TBI, (2) creation of a consultancy service by endocrine societies for use by rehabilitation centres, (3) development of continuing medical education (CME) programmes that can be offered as crossover training to the physicians who manage the care of patients with TBIs, (4) targeting of patient organizations with educational information for dissemination to patients and their families, (5) continued efforts to more clearly define the population at greatest risk of TBI-induced hypopituitarism and (6) monitor results of efficacy studies as they become available to evaluate whether and how much replacement therapy can improve the symptoms of individuals with TBI-induced hypopituitarism.",
keywords = "Growth hormone efficiency, Head trauma, Hypopituitarism, Traumatic brain injury",
author = "E. Ghigo and Brent Masel and G. Aimaretti and J. L{\'e}on-Carri{\'o}n and Casanueva, {F. F.} and Dominguez-Morales, {M. R.} and E. Elovic and K. Perrone and G. Stalla and C. Thompson and Randall Urban",
year = "2005",
month = "8",
day = "20",
doi = "10.1080/02699050400025315",
language = "English (US)",
volume = "19",
pages = "711--724",
journal = "Brain Injury",
issn = "0269-9052",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Consensus guidelines on screening for hypopituitarism following traumatic brain injury

AU - Ghigo, E.

AU - Masel, Brent

AU - Aimaretti, G.

AU - Léon-Carrión, J.

AU - Casanueva, F. F.

AU - Dominguez-Morales, M. R.

AU - Elovic, E.

AU - Perrone, K.

AU - Stalla, G.

AU - Thompson, C.

AU - Urban, Randall

PY - 2005/8/20

Y1 - 2005/8/20

N2 - Primary objective: The goal of this consensus statement is to increase awareness among endocrinologists and physicians treating patients with traumatic brain injury (TBI) of the incidence and risks of hypopituitarism among patients with TBI. Rationale: TBI poses significant risk to the pituitary gland, leading to elevated risks of diabetes, hypopituitarism and other endocrinopathies. Signs and symptoms associated with hypopituitarism often mimic the sequellae of TBI, although the severity of symptoms is not necessarily related to the severity of the injury. Patients with TBI-induced hypopituitarism may benefit both physically and psychologically from appropriate hormone replacement therapy (HRT). Participants at this unique consensus meeting attempted to define and spearhead an approach to increase awareness of the risks of TBI-induced endocrinopathies, in particular growth hormone deficiency (GHD), and to outline necessary and practical objectives for managing this condition. Recommendations: Systematic screening of pituitary function is recommended for all patients with moderate-to-severe TBI at risk of developing pituitary deficits. Patients with hypopituitarism benefit from appropriate hormonal replacement and prospects for rehabilitation of patients with TBI-induced hypopituitarism may be enhanced by appropriate HRT. Further exploration of this possibility requires: (1) active collaboration between divisions of endocrinology and rehabilitation at the local level to perform a screening of pituitary function in patients after TBI, (2) creation of a consultancy service by endocrine societies for use by rehabilitation centres, (3) development of continuing medical education (CME) programmes that can be offered as crossover training to the physicians who manage the care of patients with TBIs, (4) targeting of patient organizations with educational information for dissemination to patients and their families, (5) continued efforts to more clearly define the population at greatest risk of TBI-induced hypopituitarism and (6) monitor results of efficacy studies as they become available to evaluate whether and how much replacement therapy can improve the symptoms of individuals with TBI-induced hypopituitarism.

AB - Primary objective: The goal of this consensus statement is to increase awareness among endocrinologists and physicians treating patients with traumatic brain injury (TBI) of the incidence and risks of hypopituitarism among patients with TBI. Rationale: TBI poses significant risk to the pituitary gland, leading to elevated risks of diabetes, hypopituitarism and other endocrinopathies. Signs and symptoms associated with hypopituitarism often mimic the sequellae of TBI, although the severity of symptoms is not necessarily related to the severity of the injury. Patients with TBI-induced hypopituitarism may benefit both physically and psychologically from appropriate hormone replacement therapy (HRT). Participants at this unique consensus meeting attempted to define and spearhead an approach to increase awareness of the risks of TBI-induced endocrinopathies, in particular growth hormone deficiency (GHD), and to outline necessary and practical objectives for managing this condition. Recommendations: Systematic screening of pituitary function is recommended for all patients with moderate-to-severe TBI at risk of developing pituitary deficits. Patients with hypopituitarism benefit from appropriate hormonal replacement and prospects for rehabilitation of patients with TBI-induced hypopituitarism may be enhanced by appropriate HRT. Further exploration of this possibility requires: (1) active collaboration between divisions of endocrinology and rehabilitation at the local level to perform a screening of pituitary function in patients after TBI, (2) creation of a consultancy service by endocrine societies for use by rehabilitation centres, (3) development of continuing medical education (CME) programmes that can be offered as crossover training to the physicians who manage the care of patients with TBIs, (4) targeting of patient organizations with educational information for dissemination to patients and their families, (5) continued efforts to more clearly define the population at greatest risk of TBI-induced hypopituitarism and (6) monitor results of efficacy studies as they become available to evaluate whether and how much replacement therapy can improve the symptoms of individuals with TBI-induced hypopituitarism.

KW - Growth hormone efficiency

KW - Head trauma

KW - Hypopituitarism

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=22044436766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22044436766&partnerID=8YFLogxK

U2 - 10.1080/02699050400025315

DO - 10.1080/02699050400025315

M3 - Article

VL - 19

SP - 711

EP - 724

JO - Brain Injury

JF - Brain Injury

SN - 0269-9052

IS - 9

ER -